Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study.
Julsgaard M, Baumgart DC, Baunwall SMD, Hansen MM, Grosen A, Bibby BM, Uldbjerg N, Kjeldsen J, Sørensen HG, Larsen L, Wildt S, Weimers P, Haderslev KV, Vind I, Svenningsen L, Brynskov J, Lyhne S, Vestergaard T, Hvas CL, Kelsen J; NOVA Study Group. Julsgaard M, et al. Among authors: haderslev kv. Aliment Pharmacol Ther. 2021 Nov;54(10):1320-1329. doi: 10.1111/apt.16593. Epub 2021 Sep 2. Aliment Pharmacol Ther. 2021. PMID: 34472644
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases.
Attauabi M, Höglund C, Fassov J, Pedersen KB, Hansen HB, Wildt S, Jensen MD, Neumann A, Lind C, Jacobsen HA, Popa AM, Kjeldsen J, Pedersen N, Molazahi A, Haderslev K, Aalykke C, Knudsen T, Cebula W, Munkholm P, Bendtsen F, Seidelin JB, Burisch J. Attauabi M, et al. Scand J Gastroenterol. 2021 Sep;56(9):1040-1048. doi: 10.1080/00365521.2021.1946588. Epub 2021 Jul 5. Scand J Gastroenterol. 2021. PMID: 34224299
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data.
Attauabi M, Dahlerup JF, Poulsen A, Hansen MR, Vester-Andersen MK, Eraslan S, Prahm AP, Pedersen N, Larsen L, Jess T, Neumann A, Haderslev KV, Molazahi A, Lødrup AB, Glerup H, Oppfeldt AM, Jensen MD, Theede K, Kiszka-Kanowitz M, Seidelin JB, Burisch J. Attauabi M, et al. Among authors: haderslev kv. J Crohns Colitis. 2022 Jun 24;16(5):757-767. doi: 10.1093/ecco-jcc/jjab192. J Crohns Colitis. 2022. PMID: 34755858 Free PMC article.
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy.
Julsgaard M, Wieringa JW, Baunwall SMD, Bibby BM, Driessen GJA, Kievit L, Brodersen JB, Poulsen A, Kjeldsen J, Hansen MM, Tang HQ, Balmer CL, Glerup H, Seidelin JB, Haderslev KV, Svenningsen L, Wildt S, Juel MA, Neumann A, Fuglsang J, Jess T, Haase AM, Hvas CL, Kelsen J, Janneke van der Woude C; NEXUS Collaborator Group. Julsgaard M, et al. Among authors: haderslev kv. Clin Gastroenterol Hepatol. 2024 Jan 24:S1542-3565(24)00083-1. doi: 10.1016/j.cgh.2024.01.008. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38278191 Free article.
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study.
Attauabi M, Dahlerup JF, Poulsen A, Hansen MR, Vester-Andersen MK, Prahm AP, Pedersen N, Larsen L, Jess T, Neumann A, Haderslev KV, Molazahi A, Lødrup AB, Glerup H, Oppfeldt AM, Jensen MD, Theede K, Kiszka-Kanowitz M, Seidelin JB, Burisch J. Attauabi M, et al. Among authors: haderslev kv. Inflamm Bowel Dis. 2022 Oct 3;28(10):1618-1622. doi: 10.1093/ibd/izac052. Inflamm Bowel Dis. 2022. PMID: 35325137 Free PMC article.
19 results